Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lumen Technologies Inc (LUMN) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Lumen Technologies IncTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Lumen Technologies Inc vs Health Care Select Sector SPDR Fund — how do they compare? Lumen Technologies Inc trades at $5.3 (market cap $5.73B), while Health Care Select Sector SPDR Fund trades at $170.79 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 7.6× Lumen Technologies Inc's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Lumen Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Lumen Technologies Inc for 40 Days and Health Care Select Sector SPDR Fund for 100 Days on average.

LUMNXLV
Market Cap
$5.73B$43.48B
Volume
17,079,79911,121,431
Sector
Media—
52-Week High
$11.83$175.68
52-Week Low
$5.53$141.95
Typical Hold Time
40 Days100 Days
Enterprise Value
$17.35B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lumen Technologies Inc

LUMN trades at $5.20, down 12.01% in 24 hours, reflecting bearish technical signals and negative profitability. Revenue declined to $12.40B in 2025 with a net loss of $1.74B, though recent product launches like Intelligent Internet target AI-driven growth. The stock faces high debt levels at $17.49B long-term, while analyst consensus is predominantly Hold (60.71%) with a Reduce rating average.

The outlook remains challenged by legacy revenue declines and substantial debt, but strategic pivots to AI networking offer speculative upside. Key risks include persistent losses and competitive pressures, requiring careful monitoring of cash flow and execution on new initiatives for any sustained recovery.

Health Care Select Sector SPDR Fund

XLV trades at $170.86, up 1.21% with a bearish technical signal from moving averages while oscillators remain neutral. The healthcare ETF shows strong cost advantages with a 0.08% expense ratio compared to peers, holding 61 diversified healthcare stocks from the S&P 500. Recent news highlights XLV's defensive characteristics during potential Fed rate hikes and political volatility.

The ETF offers defensive exposure to healthcare with low costs, though technical indicators suggest near-term pressure. Key risks include sector-specific regulatory changes and election uncertainty, while the fund's diversification provides stability amid market volatility.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LUMN
100% Buy0% Sell
Avg holding period · 40 Days
XLV
44% Buy56% Sell
Avg holding period · 100 Days

Top news

Latest headlines on both assets

About Lumen Technologies Inc

With 450,000 route miles of fiber, including over 35,000 route miles of subsea fiber connecting Europe, Asia, and Latin America, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 further shifted the company's operations toward businesses (over 70% of revenue) and away from its legacy consumer business. Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen provides broadband and phone service across 37 states, where it has 4.5 million broadband customers.

Read more on LUMN →

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV →